Nestlé and Dr Reddy’s are teaming up in India to take a greater slice of the country’s dietary supplements market.
The companies have agreed to form a joint venture to develop, manufacture and sell in India – and potentially other...
By teaming up with local player Dr Reddy's, Nestlé is hoping to improve the distribution and reach of dietary supplement brands like Nature's Bounty in India. The company announced its India joint venture as it reported Q1 sales down at its Health Science business.

Nestlé and Dr Reddy’s are teaming up in India to take a greater slice of the country’s dietary supplements market.
The companies have agreed to form a joint venture to develop, manufacture and sell in India – and potentially other...
A round-up of the latest global health and wellness moves: Nestlé and Dr Reddy's name JV head; Be-sup hires comms and regulatory director; Ascendis Health appoints interim CFO.
Mentholatum says two line extensions made with 2% salicylic acid and its "Oxy for Every Kind of Ne" campaign reinforce the brand’s “commitment to tackling every type of acne—from face-ne and chin-ne to body-ne.”
Request to recall eye drops should be fulfilled promptly and businesses providing lip balms as promotional products must verify contract manufacturers are compliant, recent FDA warnings states. Additional letters went to Jordanian firm about testing alcohol for methane and to a Chinese firm advised that compliance with China’s quality control standards isn’t sufficient.
Round-up of the latest appointments in the health and wellness markets outside the US: Bayer names joint LATAM/APAC president; Haleon adds directors to board; Bionorica hires global marketing head.
Court order dismisses claims against Perrigo and Joseph Papa, its former CEO, with prejudice. Settlement also bars any claim against plaintiffs and class members, “whether arising under state, federal, common or foreign law,” alleging liability for losses.
In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry.
Proposal to have panelists rate the strength of efficacy and safety evidence on a numeric scale also draws support in written comments on ways to optimize the advisory committee process.